These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6195733)

  • 21. [Contribution to the scintigraphic diagnosis of malignant endothoracic tumors by 57Co labeled Bleomycin (author's transl)].
    Lucot H; Blasco A; Bollinelli R; Boneu A; Bru A; Combes PF; Vigoni A
    J Radiol Electrol Med Nucl; 1976 Jan; 57(1):69-78. PubMed ID: 56439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The place of 57Co-bleomycin scanning in the evaluation of tumors.
    Kahn PC; Milunsky C; Dewanjee MK; Rudders RA
    AJR Am J Roentgenol; 1977 Aug; 129(2):267-73. PubMed ID: 70990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleomycin vs gallium in the preoperative evaluation of patients with lung cancer.
    Polla BS; Slosman D
    Chest; 1986 Feb; 89(2):319. PubMed ID: 2417785
    [No Abstract]   [Full Text] [Related]  

  • 24. 57Co-bleomycin scintigraphy in staging of carcinoma of the cervix.
    Pertyński T; Durski K
    Nuklearmedizin; 1985 Feb; 24(1):48-51. PubMed ID: 2582372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of radio-labelled bleomycin for tumor detection.
    Rasker JJ; Beekhuis H; van de Poll MA; Versluis A; Jurjens H; Woldring MG
    Nuklearmedizin; 1978 Dec; 17(6):238-48. PubMed ID: 84374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of bleomycin labeled with cobalt 57 in the diagnosis of pulmonary round images].
    Vaillant G; Bertrand A; Nouel JP
    J Radiol Electrol Med Nucl; 1975; 56 suppl 1():380-2. PubMed ID: 60487
    [No Abstract]   [Full Text] [Related]  

  • 27. Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptake.
    Front D; Israel O; Iosilevsky G; Even-Sapir E; Frenkel A; Peleg H; Steiner M; Kuten A; Kolodny GM
    Radiology; 1987 Oct; 165(1):129-33. PubMed ID: 2442794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administered dose and tumor dose of bleomycin labeled with cobalt-57 in mice and men.
    Front D; Israel O; Iosilevsky G; Even-Sapir E; Ben-Haim S; Frenkel A; Ber R; Milstein D; Kolodny GM
    J Nucl Med; 1990 Nov; 31(11):1784-90. PubMed ID: 1700087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.
    Grove RB; Reba RC; Eckelman WC; Goodyear M
    J Nucl Med; 1974 Jun; 15(6):386-90. PubMed ID: 4133503
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnostic value of lung scanning with 57Co-Bleomycin].
    Mishima T; Torizumi K; Fujino Y; Hori K; Sakurai T
    Kaku Igaku; 1975 Feb; 12(1):7-11. PubMed ID: 48573
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bleomycin-Co 57 in the diagnosis of tumors of the respiratory].
    Toti A; Ciaccia A
    Arch Monaldi; 1973; 28(6):505-38. PubMed ID: 4141605
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of Bayer Map on diagnosing of 57Co-bleomycin scintigram of the lung (author's transl)].
    Takimoto M; Yokoi H; Sakurai T; Okada N; Torizumi K; Mishima T; Nishibata H; Shibazaki K
    Radioisotopes; 1979 Dec; 28(12):772-4. PubMed ID: 94676
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of bleomycin labeled with In-111 in the diagnosis of neoplasms].
    Rodari A; Turrin A; Bombardieri E; Buraggi GL
    Radiol Med; 1977 Sep; 63(9):788-9. PubMed ID: 78512
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical evaluation of scintigraphy for neoplasms with 57 Co-bleomycin].
    Watanabe K; Kawahira K; Nakayama C; Kamoi I; Matsuura K
    Rinsho Hoshasen; 1975 Jun; 20(6):495-502. PubMed ID: 51946
    [No Abstract]   [Full Text] [Related]  

  • 35. [Significance and value of scintigraphy in pulmonary diagnosis].
    Dei Poli G; Andolfi F
    Minerva Med; 1974 Oct; 65(75):3907-29. PubMed ID: 4138643
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical studies with In-111 BLEDTA, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent.
    Goodwin DA; Meares CF; DeRiemer LH; Diamanti CI; Goode RL; Baumert JE; Sartoris DJ; Lantieri RL; Fawcett HD
    J Nucl Med; 1981 Sep; 22(9):787-92. PubMed ID: 6168750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor imaging after administration of 99mTc-labeled bleomycin.
    Mori T; Hamamoto K; Onoyama Y; Torizuka K
    J Nucl Med; 1975 May; 16(5):414-22. PubMed ID: 53278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of 57Co-bleomycin delivery to brain metastases and their tumors of origin.
    Front D; Even-Sapir E; Iosilevsky G; Israel O; Frenkel A; Kolodny GM; Feinsud M
    J Neurosurg; 1987 Oct; 67(4):506-10. PubMed ID: 2443624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cobalt-57 bleomycin for imaging head and neck tumors.
    Woolfenden JM; Alberts DS; Hall JN; Patton DD
    Cancer; 1979 May; 43(5):1652-7. PubMed ID: 87253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical relevance of 111In-bleomycine in intrathoracal neoplasms (author's transl)].
    Georgi P; Schaaf J; Vogt-Moykopf I; Löhlein A; Sinn H
    Strahlentherapie; 1979 Sep; 155(9):622-7. PubMed ID: 92075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.